1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Rituximab in Membranous Nephropathy
(
- Contribution to journal › Scientific review
-
Mark
The B-Natural study—The outcome of immune tolerance induction therapy in patients with severe haemophilia B
(
- Contribution to journal › Article
-
Mark
Illness, symptoms and causes of nephrotic syndrome.
2021) In Lund University, Faculty of Medicine Licentiate Thesis(
- Thesis › Licentiate thesis
- 2020
-
Mark
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Fractional excretion of IgG in idiopathic membranous nephropathy with nephrotic syndrome: a predictive marker of risk and drug responsiveness.
(
- Contribution to journal › Article
- 2008
-
Mark
Analysis of genes encoding laminin beta 2 and related proteins in patients with Galloway-Mowat syndrome
(
- Contribution to journal › Article
- 2001
-
Mark
Plasma total homocysteine concentration in nephrotic patients with idiopathic membranous nephropathy
(
- Contribution to journal › Article
- 1999
-
Mark
Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy
(
- Contribution to journal › Article
- 1998
-
Mark
Anaphylactoid reactions and nephrotic syndrome - A considerable risk during factor IX treatment in patients with haemophilia B and inhibitors : A report on the outcome in two brothers
(
- Contribution to journal › Article
- 1997
-
Mark
Factor IX inhibitors and anaphylaxis in hemophilia B
(
- Contribution to journal › Article